bile duct

(redirected from bile duct tumors)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to bile duct tumors: Common bile duct neoplasms

bile duct

n.
Any of the excretory passages in the liver that carry bile to the hepatic duct, which joins with the cystic duct to form the common bile duct opening into the duodenum. Also called biliary duct.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

bile′ duct`


n.
a common duct that transports bile from the liver and gall bladder to the small intestine.
[1765–75]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.bile duct - a duct formed by the hepatic and cystic ducts; opens into the duodenum
duct, epithelial duct, canal, channel - a bodily passage or tube lined with epithelial cells and conveying a secretion or other substance; "the tear duct was obstructed"; "the alimentary canal"; "poison is released through a channel in the snake's fangs"
liver - large and complicated reddish-brown glandular organ located in the upper right portion of the abdominal cavity; secretes bile and functions in metabolism of protein and carbohydrate and fat; synthesizes substances involved in the clotting of the blood; synthesizes vitamin A; detoxifies poisonous substances and breaks down worn-out erythrocytes
musculus sphincter ductus choledochi - the smooth muscle sphincter of the common bile duct
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
Intraductal papillary neoplasm of the bile ducts is less common compared with BilIN, accounting for 10% to 15% of bile duct tumors. Most patients are between the ages of 50 and 60 years, with a male predominance.
The volume is color-coded to differentiate amongst the general topics, which include diseases of the gallbladder, bile duct stone disease, bile duct tumors, unusual disorders of the biliary tree, dysfunctional disorders of the sphincter of Oddi complex and the gallbladder, hereditary pancreatitis, acute pancreatitis, chronic pancreatitis, pancreatic cancer, unusual tumors of the pancreas and anpulla of Vater, and useful resources.
Exelixis' development pipeline covers cancer and metabolism and is comprised of the following compounds: XL119 (becatecarin), for which a multinational Phase III clinical trial in bile duct tumors is ongoing and which has been exclusively licensed to Helsinn Healthcare SA with rights to reacquire commercial rights for North America; XL784, initially an anticancer compound, which completed a Phase I clinical trial and is being advanced as a treatment for renal disease; XL647, XL999, XL880 and XL820, anticancer compounds currently in Phase I clinical trials; XL844 and XL184, anticancer compounds for which INDs have been filed; and multiple compounds in preclinical development for diseases including cancer and various metabolic and cardiovascular disorders.